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Two species of cysteine-proteinase inhibitors (CPIs) have been purified to homogeneity from exudate in the 
carrageenin-induced inflammation in rats. The exudate CPIs were separated into two forms (named CPI-1 
and -2) in affinity chromatography on 4carboxymethyl-papain-Sepharose, the final stage of purification. 
CPI-1 and -2 gave different mobilities in polyacrylamide gel electrophoresis (PAGE), probably because of 
different isoelectric points (~14.47 for CPI-1 and ~14.21 for CPI-2). Both CPI-1 and -2 showed immunolog- 
ical identity in double immunodiffusion and same molecular mass of 68 kDa when analysed by SDS-PAGE. 
These results indicate that CPI-1 and -2 are very similar but distinct CPIs. CPI-1 and -2 are acute-phase 
reactants and probably represent two species of T-kininogens having inhibitory activity toward cysteine pro- 
teinases. 
Acute-phase reactant Cysteine-proteinase inhibitor 
1. INTRODUCTION 
Plasma concentration of several proteins 
markedly increases in inflammation, connective 
tissue disorders and cancer [l-3]. One of these 
acute-phase reactants in rats is atMAP that is iden- 
tical to aiCP1 [4,5]. This CPI has been identified 
as T-kininogen which contains a T-kinin sequence 
(Ile-Ser-bradykinin) [6,7]. Recently, Furuto-Kato 
et al. [6] reported the close resemblance in 
nucleotide sequence between the alMAP mRNA 
and the T-prekininogen mRNAs by the cloning 
and sequence analysis of cDNAs for rat low- 
molecular-mass prekininogens including K- 
prekininogen and two types of T-prekininogens. 
The increase in plasma CPIs is due to the increase 
Abbreviations: CPI(s), cysteine-proteinase inhibitor(s); 
cyi MAP, (~1 major acute-phase protein; PAGE, 
polyacrylamide gel electrophoresis; Cm, S-car- 
boxymethyl; BAPNA, W-benzoyl-DL-arginine p- 
nitroanilide 
cc, Acute-phase protein T-kininogen Inflammation 
in T-kininogens that are able to inhibit cysteine 
proteinases [8,9]. We report here the purification 
of two types of exudate CPIs that are acute-phase 
reactants in the carrageenin-induced inflammation 
in rats. 
2. MATERIALS AND METHODS 
2.1. Materials 
DEAE-Sephacel, Sephadex G-l 50 and CNBr- 
activated Sepharose 4B were purchased from Phar- 
macia; Ampholine (pH 4-6) was from LKB In- 
struments; papain (type IV) and BAPNA from 
Sigma; gelatin and Freund’s complete adjuvant 
from Difco and carrageenin (Seakem 202) was 
from Marine Colloid Inc. All other reagents were 
of the highest purity available. 
2.2. Collection of exudate from inflamed rats 
Inflammation was induced by a subcutaneous 
injection of 4 ml of a 2% (w/v) solution of car- 
rageenin into a preformed air-pouch on the back 
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of rats (male Wistar rats weighing 150-180 g) [lo]. 
Inflammatory fluid was collected from the 
carrageenin-air pouch on day 7 after the car- 
rageenin injection and centrifuged at 100000 x g 
for 2 h at 4°C. The supernatant (exudate) was 
stored at -30°C until use. 
2.3. Purification of CPIs 
All purification procedures were carried out at 
4°C. The exudate (total 650 ml) was thawed and 
dialyzed against 0.02 M Tris-HCI buffer (pH 7.8) 
containing 2 mM CaClz and 0.02010 NaN3. The 
dialyzed exudate was chromatographed on a 
DEAE-Sephacel column (2.6 x 36 cm) with a 
linear gradient of NaCl from 0 to 0.4 M. Papain- 
inhibiting fractions from the DEAE-Sephacel col- 
umn were pooled and fractionated by 70% satura- 
tion with (NH&Sod. The resulting precipitate was 
dissolved and dialyzed against 0.05 M Tris-HCl 
buffer (pH 7.5) containing 1 M NaCI, 5 mM CaClz 
and 0.02% NaNr. The dialyzed sample was applied 
to the Sephadex G-150 column (3.2 x 85 cm) that 
had been equilibrated in the same buffer. 
Papain-inhibiting fractions obtained from gel 
filtration were pooled and dialyzed against 0.01 M 
phosphate buffer (pH 7.2) containing 0.145 M 
NaCl and 0.02% NaN3 (phosphate buffered saline, 
PBS). A portion (50 ml) of the dialyzed solution 
was applied to a Cm-papain-Sepharose 4B column 
(1.2 x 25 cm) which had been prepared according 
to Anastasi et al. [ 111. The binding proteins were 
eluted stepwise from the column with the following 
buffer [12]; (i) PBS, (ii) PBS containing 2 M 
KSCN, (iii) PBS containing 4 mM KSCN and (iv) 
0.02 M phosphate buffer (pH 12.1) containing 0.1 
M NaCl and O.O2e/‘o NaN3. Papain-inhibiting frac- 
tions obtained from the Cm-papain-Sepharose col- 
umn were dialyzed against 0.02 M Tris-HCl buffer 
(pH 7.2) containing 0.05 M NaCl and 0.02% 
NaN3, and stored at - 80°C. 
During the course of purification CPI was 
followed by measuring its papain-inhibiting 
capacity using Barrett’s method [ 131. 
2.4. Detection of CPIs by gelatin-containing 
PAGE 
CPI was detected by electrophoresis on 
polyacrylamide gel copolymerized with gelatin (a 
substrate of papain) according to Hanspal et al. 
[ 141 and Heussen and Dowdle [15]. CPI protects 
gelatin from papain digestion and is visualized as 
a band of undigested gelatin. 
2.5. PAGE and SDS-PAGE 
Two CPIs were separated by PAGE following 
the method of Davis [16], using 7% acrylamide. 
The molecular masses of CPIs were measured by 
SDS-PAGE according to Laemmli [17], using 7% 
acrylamide. Samples were reduced with 
23-mercaptoethanol just before SDS-PAGE. 
3. RESULTS 
2.3. Purification of CPIs 
Two CPIs were purified from day-7 exudate in 
three steps; DEAE-Sephacel chromatography, 
Sephadex G-150 gel filtration and affinity 
chromatography on Cm-papain-Sepharose. In the 
final stage of purification, two CPIs were suc- 
cessively eluted with KSCN and phosphate buffer 
(pH 12.1) from Cm-papain-Sepharose column 
(fig.1). The two CPIs differed in mobility in 
PAGE (fig.2) and are referred to as ‘CPI-1’ and 
‘CPI-2’, in order of elution from Cm-papain- 
Sepharose column. CPI fractions eluted with 2 M 
Fig. 1. Cm-papain-Sepharose affinity chromatography. 
Exudate CPI was partially purified by DEAE-Sephacel 
column chromatography and Sephadex G-150 gel filtra- 
tion. The partially purified CPI fraction was applied to 
Cm-papain-Sepharose column. At the points indicated 
by arrows, PBS (l), 2 M KSCN (2), 4 M KSCN (3) and 
0.02 M phosphate buffer (pH 12.1)-O. 1 M NaCl(4) were 
applied stepwise at a flow rate of 42 ml/h. Effluent frac- 
tions of 5 ml were collected and papain-inhibiting activi- 
ty of each fraction was determined. CPI-1 (fraction nos. 
31-34 and no. 56) and CPI-2 (fraction nos 84 and 85) 
were pooled separately. 
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Fig.2. PAGE at various tages in the purification of er 
udate CPIs. The samples were taken after (1) day 7; (2) 
DEAE-Sephacel chromatography; (3) (NH&SO4 
precipitation; (4) Sephadex G-150 gel filtration; Cm- 
papain-chromatography of (5) CPI-1, (6) CPI-2 and (7) 
mixture of CPI-I and CPI-2. 
KSCN had the same properties as those eluted with 
4 M KSCN and, therefore, both the fractions were 
pooled as CPI-1. CPI-1 and -2 showed reactions of 
complete immunological identity when run in dou- 
ble immunodiffusion against anti-CPI-1 rabbit 
serum (not shown), suggesting that CPI-1 and -2 
are very similar. Each of CPI-1 and -2 gave a single 
band on PAGE (fig.2), SDS-PAGE and gelatin- 
containing PAGE (fig.3). These results indicate 
that each of CPI-1 and -2 is a purified preparation. 
Table 1 summarizes the purification of exudate 
CPIs. From 650 ml of day-7 exudate we obtained 
543 mg of CPIs in the two separated species, a 
recovery of 37% (table 1). 
3.2. Properties of CPIs 
Exudate CPIs are purified into two forms, 
CPI-1 and -2, that have different mobilities in 
PAGE (fig.2). These different mobilities in PAGE 
are due to different isoelectric points; isoelectric 
points of the CPIs were ~14.47 for CPI-1 and pl 
4.21 for CPI-2 when measured by sucrose density 
gradient isoelectric focusing in pH 4-6 Ampholine. 
In SDS-PAGE the mobilities of CPI-1 and -2 were 
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indistinguishable, corresponding to iM, 68~ + 
1000 for both CPI-1 and -2. The inhibition of pa- 
pain by CPI-1 and -2 is non-competitive. Ki values 
of CPI-1 and -2 were 2.7 x lo-’ M and 4.6 x lo-’ 
M, respectively, when papain was assayed with 
BAPNA at pH 6.0 in the presence of CPI-1 or -2. 
No inhibition of serine proteinases uch as trypsin 
and chymotrypsin by CPIs was found. 
As shown in fig.3, both CPI-1 and -2 are present 
in normal rat plasma in a low concentration, 
whereas plasma and exudate levels of CPI-1 and -2 
markedly increased during the infl~mation. On 
day 2 after carrageenin injection plasma concen- 
trations of CPI-1 and -2 in the inflamed rats were 
about 14-times higher than those in normal rats 
when the amounts of CPI-1 and -2 were deter- 
mined by measuring color intensity of CPI-derived 
bands in gels after geIatin~ontaining PAGE. 
Similarly, on day 7 plasma and exudate concentra- 
tions of CPIs in the inflamed rats were about 
CPI CPI 
1 2 _-_- 
Fig.3. Gelatin-containing PAGE of plasma nd exudate. 
Plasma and exudate were obtained from inflamed rats 
on day 2 or 7 after carrageenin i jection. Norma1 plasma 
was obtained from 7-week-old rats that were about the 
same age as the inflamed rats. Dilution factors of 
samples are shown in parentheses. Purified CPI-1 and -2 
were run simultaneously. 
Volume 207, number 1 FEBS LETTERS October 1986 
Table 1 
Purification of exudate CPIs 
Stage Total volume Total protein Total activity 
(ml) (mg) (units) 
Recovery 
(To) 
Spec. act. 
(units/mg 
protein) 
Purification 
factor 
Day-7 exudate 
DEAE-Sephacel 
Sephadex G- 150 
Cm-papain- 
Sepharose 
CPI-1 
CPI-2 
650 28535 3380 100 0.119 1.0 
360 9479 2524 75 0.266 2.3 
413 4766 1830 54 0.384 3.2 
184 322 767 23 2.383 20.1 
108 221 455 14 2.059 17.4 
Units of CPI are defined as mg of papain inhibited in the assay system. Protein was measured by the method of Lowry 
et al. [19], using bovine serum albumin as a standard 
9-times higher than plasma concentration of CPIs 
in normal rats. These results indicate that both 
CPI-1 and -2 are acute-phase reactants in the 
carrageenin-induced inflammation in rats. 
4. DISCUSSION 
Plasma concentration of CPI-1 and -2 markedly 
increased in the acute phase and a high concentra- 
tion of exudate CPIs was found in the chronic 
phase of the carrageenin-induced inflammation in 
rats (fig.3). Esnard and Gauthier [5] demonstrated 
that rat (YIMAP is identical to cuiCP1. They also 
found that the ai-CPI gave two electrophoretically 
distinct components on PAGE but a single band of 
M, 68000 on SDS-PAGE. On the basis of 
molecular mass and properties on PAGE, these 
two distinct components in acute-phase rat serum 
are probably identical to CPI-1 and -2 that we have 
purified from rat exudate in this study. It has been 
shown by Bauer et al. [18] that molecular masses 
of rat cviMAP are 68 kDa for a secreted form and 
63.5 kDa for an intracellular unglycosylated form 
when determined by SDS-PAGE. Recently, 
Furuto-Kato et al. [6] demonstrated that rat low- 
molecular-mass prekininogens are encoded by at 
least three very similar but distinct mRNAs (K- 
prekininogen, T-prekininogen I and II mRNAs) 
and indicated a close similarity between mRNA of 
rat alMAP and each mRNA of two species of rat 
T-prekininogens. In addition, Kageyama et al. [9] 
found that the T-prekininogen I and II mRNAs in- 
crease about lo- and 13-fold over their normal 
levels after induction of inflammation. A high 
plasma concentration of CPIs in rats having adju- 
vant arthritis is almost solely due to the increase in 
T-kininogen [8]. These findings strongly suggest 
that CPI-1 and -2 correspond to two species of T- 
kininogens that have the ability to inhibit cysteine 
proteinases and markedly increase in an acute 
phase of inflammation in rats [4-8,181. 
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